Baiyunshan Sustainability Profile
Baiyunshan, officially known as Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, is a prominent player in the pharmaceutical industry, headquartered in Guangzhou, China. Established in 1997, the company has made significant strides in the development and production of traditional Chinese medicine, Western pharmaceuticals, and health products, catering to both domestic and international markets. With a strong focus on research and innovation, Baiyunshan offers a diverse range of core products, including herbal remedies and modern pharmaceuticals, distinguished by their quality and efficacy. The company has achieved notable recognition within the industry, positioning itself as a leader in the integration of traditional and modern medicinal practices. Baiyunshan continues to expand its operational footprint, contributing to the advancement of healthcare solutions in China and beyond.
DitchCarbon Score
How does Baiyunshan's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Baiyunshan's score of 19 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Baiyunshan's reported carbon emissions
In 2025, Baiyunshan reported emissions intensity of approximately 16.0 kg CO2e per kg of aluminium and 5.3 kg CO2e per kg of steel, reflecting their ongoing production activities. The previous year, 2024, saw a slightly higher emissions intensity of about 17.3 kg CO2e per kg of aluminium and 4.8 kg CO2e per kg of steel. In 2021, the emissions intensity for aluminium was about 19.4 kg CO2e per kg, while for steel, it was approximately 5.0 kg CO2e per kg. Baiyunshan has not disclosed specific Scope 1, 2, or 3 emissions data, nor have they set formal reduction targets or climate pledges. Their emissions data is inherited from their parent company, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, but no specific climate initiatives or commitments have been reported. Overall, while Baiyunshan provides emissions intensity figures, they currently lack comprehensive emissions data and formal climate commitments, indicating a potential area for future improvement in their sustainability strategy.
How Carbon Intensive is Baiyunshan's Industry?
How Carbon Intensive is Baiyunshan's Location?
Baiyunshan's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Baiyunshan has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
